Evidence map›Paper›PMID 27275601›Full record

ArticlePloS one2016

Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

Panayotis K Thanos, Ronald Kim, Foteini Delis, Mala Ananth, George Chachati, Mark J Rocco, Ihssan Masad, Jose A Muniz, Samuel C Grant, Mark S Gold and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. PGx-BasedCurrent neuropharmacology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Stimulant medications in children with ADHD normalize the structure of brain regions associated with attention and reward.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Role of Microglia in Psychostimulant Addiction.Current neuropharmacology · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Panayotis K ThanosBehavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, United States of America.
Ronald KimDepartment of Psychology, UNC Chapel Hill, Chapel Hill, NC, United States of America.
Foteini DelisDepartment of Pharmacology, School of Medicine, University of Ioannina, Ioannina, Greece.
Mala AnanthDepartment of Neuroscience, Stony Brook University, Stony Brook, NY, United States of America.
George ChachatiBehavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, United States of America.
Mark J RoccoBehavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, United States of America.
Ihssan MasadDepartment of Biomedical Systems and Informatics Engineering, Hijjawi Faculty for Engineering Technology, Yarmouk University, Irbid 21163, Jordan
Jose A MunizNational High Magnetic Field Laboratory, Tallahassee, FL, United States of America.
Samuel C GrantNational High Magnetic Field Laboratory, Tallahassee, FL, United States of America.
Mark S GoldWashington University School of Medicine, Department of Psychiatry, St. Louis, MO, United States of America.
Jean Lud CadetMolecular Neuropsychiatry Research Branch, NIDA, NIH, Department of Health and Human Services, Baltimore, MD, United States of America.
Nora D VolkowLaboratory of Neuroimaging, NIAAA, NIH, Department of Health and Human Services, Bethesda, MD, United States of America.
National High Magnetic Field Laboratory · USStony Brook University · USUniversity of Ioannina · GRUniversity of North Carolina at Chapel Hill · USWashington University in St. Louis · USYarmouk University · JO

Funding

Neurobiology of Substance Abuse and AddictionZIAAA000550 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI VOLKOW, NORA D. · 2009 to 2025
$115.1M
Mapping the Genes for Ethanol-Related PhenotypesR01AA011034 · NIAAA · STATE UNIVERSITY NEW YORK STONY BROOK · PI HITZEMANN, ROBERT J. · 1996 to 2014
$5.1M
NIAAA NIH HHS R01 AA011034
6 · The paper itself

Abstract

Methamphetamine (MA) addiction is a growing epidemic worldwide. Chronic MA use has been shown to lead to neurotoxicity in rodents and humans. Magnetic resonance imaging (MRI) studies in MA users have shown enlarged striatal volumes and positron emission tomography (PET) studies have shown decreased brain glucose metabolism (BGluM) in the striatum of detoxified MA users. The present study examines structural changes of the brain, observes microglial activation, and assesses changes in brain function, in response to chronic MA treatment. Rats were randomly split into three distinct treatment groups and treated daily for four months, via i.p. injection, with saline (controls), or low dose (LD) MA (4 mg/kg), or high dose (HD) MA (8 mg/kg). Sixteen weeks into the treatment period, rats were injected with a glucose analog, [18F] fluorodeoxyglucose (FDG), and their brains were scanned with micro-PET to assess regional BGluM. At the end of MA treatment, magnetic resonance imaging at 21T was performed on perfused rats to determine regional brain volume and in vitro [3H]PK 11195 autoradiography was performed on fresh-frozen brain tissue to measure microglia activation. When compared with controls, chronic HD MA-treated rats had enlarged striatal volumes and increases in [3H]PK 11195 binding in striatum, the nucleus accumbens, frontal cortical areas, the rhinal cortices, and the cerebellar nuclei. FDG microPET imaging showed that LD MA-treated rats had higher BGluM in insular and somatosensory cortices, face sensory nucleus of the thalamus, and brainstem reticular formation, while HD MA-treated rats had higher BGluM in primary and higher order somatosensory and the retrosplenial cortices, compared with controls. HD and LD MA-treated rats had lower BGluM in the tail of the striatum, rhinal cortex, and subiculum and HD MA also had lower BGluM in hippocampus than controls. These results corroborate clinical findings and help further examine the mechanisms behind MA-induced neurotoxicity.

Indexed as

BrainNeurotoxicity SyndromesPositron-Emission TomographySubstance-Related DisordersAnimalsChronic DiseaseFluorodeoxyglucose F18MaleMethamphetamineRatsRats, Sprague-DawleyFluorodeoxyglucose F18Methamphetamine

Identifiers

PMID27275601
PMCPMC4898739
OpenAlexW2411894862

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.